Dissertation/Thesis Abstract

Comparative Effects of Tolfenamic Acid and Donepezil on Behavior and Tau Pathology Biomarker Levels
by Alharbi, Abdullah G., M.S., University of Rhode Island, 2019, 54; 27668714
Abstract (Summary)

Alzheimer’s disease (AD) is a progressive neurodegenerative disease and is considered the predominant cause of dementia worldwide. Pathologically, the disease has been attributed to excessive accumulation of amyloid-β peptide and hyperphosphorylated tau protein leading to the formation of amyloid plaques and tau tangles, respectively. Currently, management of AD is extensively based on cholinesterase inhibitors, such as donepezil (DPZ), which provide symptomatic improvement. While there is no disease-modifying treatment, our lab has shown that tolfenamic acid (TA), a non-steroidal anti-inflammatory drug (NSAID), has potential disease-modifying properties independent of its anti-inflammatory effects. Thus, here we intended to compare it with DPZ, the most commonly prescribed treatment for AD, on behavior and tau pathology biomarker levels using an hTau transgenic mouse model and an in vitro model. A prototypical NSAID, ibuprofen (IBP), was used to further confirm that TA’s effects are independent of its anti-inflammatory properties. Our findings show that total tau and its hyperphosphorylation levels were reduced in TA and DPZ treated mice, and IBP had no such effects on these markers. Treatments that reduced tau levels provided consistent improvement of cognitive performance as measured by the Morris Water Maze (MWM). Further we demonstrated TA effects on neuroblastoma cell line in which both TA and DPZ reduced total tau protein level, but not ibuprofen.

Indexing (document details)
Advisor: Zawia, Nasser H.
Commitee: Quinlan, Katharina A., Weyandt, Lisa L.
School: University of Rhode Island
Department: Pharmaceutical Sciences
School Location: United States -- Rhode Island
Source: MAI 81/6(E), Masters Abstracts International
Source Type: DISSERTATION
Subjects: Pharmacology
Keywords: Alzheimer’s disease, Cognitive performance, Comparative study, Donepezil, Tau pathology, Tolfenamic acid
Publication Number: 27668714
ISBN: 9781392353998
Copyright © 2020 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest